Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-30
DOI
10.3389/fbioe.2020.00862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 is an appropriate name for the new coronavirus
- (2020) Yuntao Wu et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship
- (2020) Volodymyr V. Oberemok et al. INFLAMMATION RESEARCH
- Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes
- (2020) Grace L. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comorbidities and multi-organ injuries in the treatment of COVID-19
- (2020) Tianbing Wang et al. LANCET
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
- (2020) Firas A. Rabi et al. Pathogens
- Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
- (2020) Mark P. Lythgoe et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2
- (2018) Ning Li et al. Science Bulletin
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Escherichia coli-derived virus-like particles in vaccine development
- (2017) Xiaofen Huang et al. npj Vaccines
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
- (2014) Jenny G.H. Low et al. VACCINE
- Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles
- (2012) Qinjian Zhao et al. Nanomedicine-Nanotechnology Biology and Medicine
- Virus-like particle (VLP)-based vaccines for pandemic influenza
- (2012) Constantino López-Macías Human Vaccines & Immunotherapeutics
- Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice
- (2010) Chuan Li et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now